Can we Prevent Antibiotic Resistance?
Antibiotics have saved countless lives since they were introduced in the 1940s, curing infections and making procedures like chemotherapy and surgeries safer. But as bacteria evolve, many have become resistant to antibiotics.
CARB-X Funds Sutrovax to Develop a New Vaccine to Prevent Group A Streptococcal Infections
Vaccines are essential in the global fight against drug-resistant bacteria .
CARB-X funds Vaxxilon AG to Develop a New Vaccine to Prevent Superbug Infections
The vaccine aims to prevent deadly hospital-acquired respiratory, urinary-tract, and other infections that kill thousands of patients each year.
CARB-X Funds BB100 to Treat Hyper-Virulent Multi-Drug-Resistant E. coli Infections
New alternative-to-antibiotic treatment in development to fight infections associated with E. coli superbug.
CARB-X Funds Debiopharm to Develop a New Class of Antibiotics to Treat Hospital-Acquired Pneumonia
Debiopharm’s new Debio 1454 is the company’s second project to be awarded CARB-X support
CARB-X Expands its Global Accelerator Network
Life sciences organizations from around the world brought together to support the development of antibiotics, rapid diagnostics, vaccines and other life-saving products to combat drug-resistant superbugs.
CARB-X Calls for New ‘Open Science’ Era in Antibacterial Innovation
BU Law-based antibiotic accelerator asserts that sharing scientific data will help speed the delivery of new antibiotics and other life-saving products to fight superbugs.
BU Law Professors Plan to Study Impact of Biopharmaceutical Funder CARB-X
Professors Michael Meurer and James Bessen join interdisciplinary team examining data from BU Law-based accelerator.
CARB-X Funds SciBac to Develop a Microbe Drug that Kills C. Difficile Superbugs
An alternative to antibiotics, this microbe pill would boost the body’s microbiome to kill the Clostridium difficile bacteria and prevent recurrent C. difficile infections.
CARB-X Funds Summit Therapeutics to Support Development of a New Class of Antibiotic to Treat Gonorrhoea Superbug
New class of antibiotics targets the urgent global threat of gonorrhoea bacterial infections.